Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Flowgoon Nov 08, 2016 11:15am

163 Views

Post# 25436711

RE:I got in a $.10 this morning

Hey Smith,

Remember seeing you around in the old days lol. The market cap is tiny for NF, they seem to have found a very cool niche in the market. Their revenue projections are much greater than the market cap at this stage and with revenue starting to roll in now, this share price is waaay too low.

I think I actually like NF better than EAT, and EAT has a much higher market cap. Have a whack of EAT but NF is going to ramp up very quickly if management keeps executing.

All the best, welcome aboard!

Bullboard Posts

How a junior advances one of the largest undeveloped diamond projects